Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
China · Delayed Price · Currency is CNY 28.00
-0.44 (-1.55%)
At close: Jun 2, 2026
SHE:301166 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -25.24 | -22.95 | 10.15 | 40.32 | 106.6 | 108.73 |
Depreciation & Amortization | 23.44 | 23.44 | 22.41 | 18.88 | 11.67 | 6.65 |
Other Amortization | 5.35 | 5.35 | 3.46 | 2.77 | 1.08 | 0.64 |
Loss (Gain) From Sale of Assets | 0.38 | 0.38 | 0.91 | 0 | -0.03 | 0.24 |
Asset Writedown & Restructuring Costs | - | - | 0 | 0 | 0.02 | 0 |
Loss (Gain) From Sale of Investments | -20.72 | -20.72 | -29.45 | -30.03 | -22.61 | - |
Provision & Write-off of Bad Debts | 10.05 | 10.05 | 6.14 | 3.73 | 11.21 | 3 |
Other Operating Activities | -89.59 | 5.28 | 3.52 | 15.74 | 6.26 | 0.17 |
Change in Accounts Receivable | 0.67 | 0.67 | 24.79 | -11.31 | -159.35 | -56.97 |
Change in Inventory | -1.64 | -1.64 | 71.49 | -43.59 | -93.06 | -33.02 |
Change in Accounts Payable | 66.8 | 66.8 | -18.14 | 9.49 | 4.15 | 32.97 |
Change in Other Net Operating Assets | -1.17 | -1.17 | 0.12 | -3.38 | 3.38 | - |
Operating Cash Flow | -44.73 | 52.43 | 75.97 | -22.69 | -143.3 | 59.02 |
Operating Cash Flow Growth | - | -30.98% | - | - | - | -36.00% |
Capital Expenditures | -79.68 | -96.05 | -71.2 | -63.18 | -61.5 | -14.31 |
Sale of Property, Plant & Equipment | 0.08 | 0.09 | 0.02 | 0.11 | 0.11 | 0.11 |
Investment in Securities | 21.72 | -256.82 | 471.5 | -113.47 | -977.5 | - |
Other Investing Activities | 18.29 | 18.45 | 31.39 | 26.8 | 20.61 | - |
Investing Cash Flow | -39.58 | -334.33 | 431.71 | -149.74 | -1,018 | -14.2 |
Short-Term Debt Issued | - | - | - | - | 80 | - |
Long-Term Debt Issued | - | 44.47 | 0.01 | - | - | - |
Total Debt Issued | 69.47 | 44.47 | 0.01 | - | 80 | - |
Short-Term Debt Repaid | - | - | - | - | - | -10 |
Long-Term Debt Repaid | - | -7.69 | -8.92 | -88.9 | -5.42 | -2.18 |
Total Debt Repaid | -7.69 | -7.69 | -8.92 | -88.9 | -5.42 | -12.18 |
Net Debt Issued (Repaid) | 61.78 | 36.78 | -8.91 | -88.9 | 74.58 | -12.18 |
Issuance of Common Stock | - | - | - | - | - | 1,617 |
Repurchase of Common Stock | -18.26 | -18.26 | -19.5 | - | - | - |
Common Dividends Paid | -19.98 | -19.98 | -40.72 | -78.84 | -44.26 | -20.2 |
Dividends Paid | -19.98 | -19.98 | -40.72 | -78.84 | -44.26 | -20.2 |
Other Financing Activities | 3.33 | - | - | - | -11.15 | -6.8 |
Financing Cash Flow | 26.86 | -1.46 | -69.12 | -167.74 | 19.17 | 1,578 |
Foreign Exchange Rate Adjustments | -4.07 | -2.95 | 0.71 | 0.6 | 1.69 | -0.41 |
Net Cash Flow | -61.52 | -286.31 | 439.26 | -339.57 | -1,141 | 1,622 |
Free Cash Flow | -124.41 | -43.62 | 4.77 | -85.87 | -204.8 | 44.72 |
Free Cash Flow Growth | - | - | - | - | - | -48.77% |
Free Cash Flow Margin | -11.04% | -4.03% | 0.43% | -7.00% | -17.14% | 4.03% |
Free Cash Flow Per Share | -1.43 | -0.49 | 0.06 | -1.00 | -2.36 | 0.68 |
Cash Income Tax Paid | 43.76 | 31.44 | 46.06 | 43.53 | 42.82 | 70 |
Levered Free Cash Flow | -132.92 | -75.13 | -13.2 | -11.95 | -238.05 | 31.39 |
Unlevered Free Cash Flow | -132.36 | -74.56 | -12.55 | -10.67 | -237.24 | 31.46 |
Change in Working Capital | 51.6 | 51.6 | 58.84 | -74.1 | -257.51 | -60.41 |